Press Releases

The global pharmaceutical landscape is evolving at an extraordinary pace as manufacturing capabilities, drug development technologies, and regulation advances creating new ways of innovating drugs and better serving patients. CPhI Worldwide is using its unrivalled access to pharmaceutical professionals and...

AstraZeneca announced that it has received marketing authorisation from China’s National Medical Products Administration (NMPA) for Tagrisso (osimertinib) as a 1st-line treatment for adults with locally-advanced or metastatic non-small cell lung cancer (NSCLC) whose tumours have the genetic mutations...

Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have entered into a collaboration to develop a pathway to precision medicine through the development of robust, reliable and sensitive liquid chromatography...

ManuPharma is the World’s most senior advanced pharma manufacturing conference. Tackling both small molecule and biologics manufacturing challenges at a strategic level, it allows senior pharma manufacturing decision makers to meet, benchmark, and learn from real examples - delivered...

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has started large-scale production of Nanologica’s silica particles. Nanologica is a nanotechnology company specialising in the development of silica for application in drug development and chromatography. The company recently signed a...

BioCity, the pioneering life science incubator and business collective, has announced investment in precision medicine biotech, Kinomica Ltd., via the Innovate UK Precision Medicine Investment Accelerator. Spun out from Barts Cancer Institute, Queen Mary University of London, Kinomica Ltd is...

Signant Health, formerly CRF Health and Bracket, has appointed Anthony Todd Everhart, MD, FACP to the Signant Health Science and Medicine Team as Clinical Vice President, Internal Medicine, reporting to the Chief Medical Officer, Dr. David Daniel. As a technology...